Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: EC Formally Authorises COVID-19 Drugs From Regeneron-Roche, Celltrion

Nov 12 (Reuters) - European Medicines Agency (EMA):
    * EMA: THE EUROPEAN COMMISSION AUTHORISED THE COVID-19
TREATMENTS
REGKIRONA (REGDANVIMAB) AND RONAPREVE (CASIRIVIMAB / IMDEVIMAB),
FOLLOWING EVALUATION BY EMA: 12/11/2021


 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Celltrion Healthcare Co

See all news